Company Valuation: ResMed, Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 35,903 30,691 32,133 28,117 37,762 37,195 - -
Change - -14.52% 4.7% -12.5% 34.31% -1.5% - -
Enterprise Value (EV) 1 36,263 31,192 33,346 28,585 37,221 36,129 35,311 34,232
Change - -13.98% 6.9% -14.28% 30.21% -2.93% -2.26% -3.06%
P/E ratio 76.1x 39.6x 35.9x 27.7x 27.1x 24.1x 21.6x 19.8x
PBR 12.4x 9.35x 7.76x 5.78x 6.33x 5.45x 4.78x 4.43x
PEG - 0.6x 2.4x 2x 0.7x 2.1x 1.9x 2.12x
Capitalization / Revenue 11.2x 8.58x 7.61x 6x 7.34x 6.59x 6.13x 5.73x
EV / Revenue 11.3x 8.72x 7.9x 6.1x 7.23x 6.4x 5.82x 5.27x
EV / EBITDA 33.8x 26.8x 25.3x 18.1x 19.8x 16.4x 14.9x 13.3x
EV / EBIT 40.1x 31.2x 27.2x 19.3x 21.1x 17.6x 15.8x 14.1x
EV / FCF 57.2x 144x 58.1x 22x 22.4x 23.7x 21.1x 19x
FCF Yield 1.75% 0.69% 1.72% 4.55% 4.46% 4.21% 4.74% 5.25%
Dividend per Share 2 1.56 1.68 1.8 1.92 2.12 2.434 2.696 2.635
Rate of return 0.63% 0.8% 0.82% 1% 0.82% 0.95% 1.06% 1.03%
EPS 2 3.24 5.3 6.09 6.92 9.51 10.59 11.81 12.92
Distribution rate 48.1% 31.7% 29.6% 27.7% 22.3% 23% 22.8% 20.4%
Net sales 1 3,197 3,578 4,223 4,685 5,146 5,645 6,069 6,494
EBITDA 1 1,074 1,162 1,317 1,576 1,884 2,198 2,367 2,578
EBIT 1 903.7 1,000 1,224 1,478 1,763 2,050 2,240 2,425
Net income 1 474.5 779.4 897.6 1,021 1,401 1,543 1,727 1,890
Net Debt 1 360.1 501.5 1,213 468.9 -541.2 -1,066 -1,883 -2,963
Reference price 2 246.52 209.63 218.50 191.42 258.00 255.32 255.32 255.32
Nbr of stocks (in thousands) 145,640 146,405 147,062 146,884 146,365 145,678 - -
Announcement Date 5/8/21 11/8/22 3/8/23 1/8/24 31/7/25 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
24.47x6.5x16.68x0.94% 37.74B
26.32x4.61x18.01x0.36% 190B
56.72x14.7x34.21x-.--% 178B
31.99x6.04x18.92x0.65% 145B
29.49x5.06x16.37x-.--% 107B
20.88x2.42x12.02x2.53% 53.73B
29.57x6.74x21.66x-.--% 49.5B
16.35x1.85x10x0.21% 36.01B
23.12x4.74x16.41x0.85% 34.06B
26.95x5.56x17.43x-.--% 31.3B
Average 28.59x 5.82x 18.17x 0.55% 86.27B
Weighted average by Cap. 33.18x 6.98x 20.66x 0.43%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Valuation ResMed, Inc.